Login to Your Account

Macrogenics ‘DART[s]’ into IPO Queue and Seeks $60M

By Jennifer Boggs
Managing Editor

Friday, September 6, 2013
Macrogenics Inc. joined the roster of biotechs to file for initial public offerings (IPOs) this year, filing an S-1 with aims of raising up to $60 million to support its cancer drug pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription